# Allygen Biologics funding rounds and investors

As of 17 Oct 2026, Allygen Biologics has raised $44.8M across 1 verified round on record (amounts in other currencies converted to USD); latest: over RMB 300 million (≈ US$42 million) Series A led by Sherpa Healthcare Partners, announced 13 Oct 2026.

Innovative biotechnology, targeted conjugate drugs

Headquarters: Shanghai, China  
Page: https://fireround.dev/companies/allygen-biologics

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-10-13 | Series A | over RMB 300 million (≈ US$42 million) | Sherpa Healthcare Partners | Beijing Medical and Health Industry Investment Fund, Beijing Pharmaceutical and Health Industry Investment Fund, Huagai Capital, Qiming Venture Partners, Taiyu Investment, TigerYeah Capital, W Capital, Zhuhai Science and Technology Industry Group | [flcube.com](https://flcube.com/allygen-biologics-closes-over-rmb-300-million-series-a-led-by-sherpa-healthcare-partners-funding-to-propel-star-biadc-candidate-alg01-into-phase-1), [en.tmtpost.com](https://en.tmtpost.com/news/8166696) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.